From Discovery to Clinical Translation: High-Precision Protein Quantification with SISCAPA Immuno-MS

Deciphering Protein Corona Assembly and Non-Canonical Translation of mRNA-LNPs – Sanofi

Quantifying and Understanding Phosphoproteome Turnover: From In Vitro to In Vivo – Yale University

Large-scale proteomic analysis of biofluids for identification of biomarkers for amyloid conversion

Parallelizing Spectronaut directDIA – The Broad Institute

Spectronaut User Meeting 2026 – Welcome

Labeled DIA Workflows

Using Immunopeptidomics to understand how ERAP1 inhibition reshapes the immunopeptidome

PTM Analysis Workflow: Input Normalization & Stoichiometry

Spectronaut 19: Unlock Your Data's True Story

US HUPO 2025 Breakfast Seminar

AO HUPO 2024 - Data & AI Driven DIA Analysis

Development of a Quantitative CSF LRRK2 Assay to Support Clinical Studies

Mass Spectrometry-based Approaches to Targeted Protein Degradation Drug Discovery and Development

Utilizing Multi-Omic Data to Drive Expansion of the Cancer Immunopeptidome

Emerging Applications of Single FFPE Slide Proteomics in Clinical and Translational Research

Biomarker Discovery Programme of OMO-103, a First-in-modality MYC Inhibitor

Accelerating Drug Discovery and Development with Biognosys’ Next-Generation Proteomics Services

Proteoverse® Digital Proteome​ presented at ASMS 2025, Baltimore, by Sandra Schaer

Accelerating Drug Development with Biognosys’ Next-Generation Proteomics Services

Quantitative Analysis of the Immunopeptidome as a Pharmacodynamic Biomarker For ERAP Inhibitors

Circulating Biomarker Discovery for Amyloid Conversion and Cognitive Decline

Increasing the identification of ERAP1 inhibitor dependent antigens with Spectronaut 20

Spectronaut 20: A New Era for directDIA

Elevating the Scale and Depth of DIA Proteomics with New Spectronaut Workflows

From Data to Discovery: Maximizing Insights into Molecular Mechanisms with Spectronaut®

Spectronaut: Post-Analysis Perspective

Spectronaut: Analysis Perspective - Reviewing Visualized Data

Spectronaut: Analysis Perspective - Setting up DIA Analysis

Spectronaut® 17: A Groundbreaking Increase in Identifications

Spectronaut: The Perfect Partner for Single-cell Proteomics in DIA Mode - US HUPO 2023

Spectronaut® 18: Limitless Throughput. Unparalleled Efficiency.

Biognosys' MS Facility Inauguration 2024 in Newton, MA (USA)

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Spectronaut: Library Perspective

Spectronaut: Database Perspective

Spectronaut: Software Overview

Spectronaut: Installation

Tutorial Series: Everything You Need to Know About Spectronaut®

TrueDiscovery® Higher Throughput Research Services | Biognosys SpotLight

Biognosys at ASMS 2023

Biognosys at ASMS 2023

Biognosys at the AACR Annual Meeting 2023

Biognosys & Bruker Strategic Partnership | Biognosys SpotLight

Biognosys at AACR Annual Meeting 2023

Immunopeptidome Profiling | Biognosys SpotLight

Biognosys & NeoGenomics Partnership | Biognosys SpotLight

Spectronaut 17: A Groundbreaking Increase in Identifications

New Horizons, Expanding Possibilities | Biognosys' Cambridge (MA) Office Inauguration

Enhance Your Plasma Research with Biognosys’ PQ500™ Reference Peptides

Spectronaut 16: Reaching New Depths in DIA Proteomics with AI - ASMS 2022

Spectronaut: The Best Ally for Your Visionary Projects - ASMS 2022

Biognosys at ASMS 2021

Biognosys at ASMS 2022

Transformative Proteomics Insights From Discovery to Clinic

Biognosys’ Cambridge (MA) Office Inauguration Event

SpectroDive Tutorial: How to Perform Absolute Quantification Using Calibration Curves

10 years of Spectronaut: Our Favorite Things

Going Deep Into the Tissue Proteome | Biognosys SpotLight

Biognosys at ASMS 2022